Gene · 4214
Papers4,517
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,517
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma. | Clin Res Hepatol Gastroenterol | 2024 | 39069260 | PubTator, text mining | PubMed |
| A comprehensive physiological and -Omic analysis of trypsin-mediated protection of green pepper fruits from chilling injury. | Food Chem | 2024 | 39068792 | PubTator, text mining | PubMed |
| Deafness DFNB128 Associated with a Recessive Variant of Human MAP3K1 Recapitulates Hearing Loss of Map3k1-Deficient Mice. | Genes (Basel) | 2024 | 39062623 | PubTator, text mining | PubMed |
| Identifying potential drug targets in the kinomes of two monogenean species. | Helminthologia | 2024 | 39040804 | PubTator, text mining | PubMed |
| Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization. | Eur J Pharmacol | 2024 | 39038636 | PubTator, text mining | PubMed |
| Identification of rare genetic variants for rotator cuff tearing and repair in high-risk pedigrees. | JSES Int | 2024 | 39035665 | PubTator, text mining | PubMed |
| Mitogen signaling strength and duration can control cell cycle decisions. | Sci Adv | 2024 | 38968359 | PubTator, text mining | PubMed |
| Immunotherapy-relevance of a candidate prognostic score for Acute Myeloid Leukemia. | Heliyon | 2024 | 38961904 | PubTator, text mining | PubMed |
| Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants. | Front Genet | 2024 | 38915825 | PubTator, text mining | PubMed |
| Crosstalk of MAP3K1 and EGFR signaling mediates gene-environment interactions that block developmental tissue closure. | J Biol Chem | 2024 | 38897570 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. | Cancer Med | 2024 | 38895905 | PubTator, text mining | PubMed |
| Identification of a novel monocyte/macrophage-related gene signature for predicting survival and immune response in acute myeloid leukemia. | Sci Rep | 2024 | 38890346 | PubTator, text mining | PubMed |
| Clinicopathological and Molecular Features of Penile Melanoma With a Proposed Staging System. | Am J Surg Pathol | 2024 | 38808927 | PubTator, text mining | PubMed |
| To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment. | Front Immunol | 2024 | 38726002 | PubTator, text mining | PubMed |
| Corrigendum to "miR-196b inhibits cell migration and invasion through targeting MAP3K1 in hydatidiform mole" [Biomed. Pharmacother. 113 (2019) 108760]. | Biomed Pharmacother | 2024 | 38677924 | PubTator, text mining | PubMed |
| Prognostic impact of tumor-associated neutrophils in breast cancer. | Int J Clin Exp Pathol | 2024 | 38577697 | PubTator, text mining | PubMed |
| Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer. | Breast Cancer Res Treat | 2024 | 38523186 | PubTator, text mining | PubMed |
| Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing. | ESMO Open | 2024 | 38387111 | PubTator, text mining | PubMed |
| RelA and mitogen-activated protein kinase kinase kinases potently enhance lentiviral vector production. | Biochem Biophys Rep | 2024 | 38328371 | PubTator, text mining | PubMed |
| Stress biology: Complexity and multifariousness in health and disease. | Cell Stress Chaperones | 2024 | 38311120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4214/papers?page=7